High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
Latest Information Update: 13 Sep 2019
At a glance
- Drugs Natural killer cell therapy Shenzhen Hank Bioengineering Institute (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Sep 2019 Status changed from recruiting to completed.
- 10 Jan 2017 New trial record